Millennium Management
WINT

Millennium Management’s Windtree Therapeutics Inc WINT Stock Holding History

Millennium Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,400
Closed -$140K – 4128
2015
Q1 		$140K Buy
+8,400
New +$165K ﹤0.01% 3367

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Millennium Management's WINT Position: Q4 2016 in Review

Millennium Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2016, closing a stake of 58,874 shares — an estimated $151K sold.

Millennium Management first reported a position in WINT in Q4 2013 and held it in 12 quarters. The position peaked at $4.59M in Q4 2013. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

  • Millennium Management reported no remaining Windtree Therapeutics Inc position as of Q4 2016 after selling out during the quarter.
  • Millennium Management sold 58,874 Windtree Therapeutics Inc shares in Q4 2016, an estimated $151K.
  • Millennium Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 12 quarters.
  • Millennium Management's Windtree Therapeutics Inc position peaked at $4.59M in Q4 2013.
  • 31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.